Drug-resistant tuberculosis threatens WHO's End-TB strategy

被引：23
作者：
Mariandyshev, Andrei [1 ]
Eliseev, Platon [1 ]
机构：
[1] Northern State Med Univ, Arkhangelsk, Russia
来源：
LANCET INFECTIOUS DISEASES | 2017年 / 17卷 / 07期
关键词：
D O I：
10.1016/S1473-3099(17)30246-3
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：674 / 675
页数：2
相关论文
共 10 条
  • [1] [Anonymous], 2016, GLOB TUB REP
  • [2] [Anonymous], 2013, The use of Bedaquiline in the treatment of m ultidrug-resistant tuberculosis. Interim policy guidance
  • [3] [Anonymous], 2016, ROAD END TB HIGHL 30
  • [4] [Anonymous], 2014, US DEL TREATM MULT R
  • [5] Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
    Cegielski, J. Peter
    Dalton, Tracy
    Yagui, Martin
    Wattanaamornkiet, Wanpen
    Volchenkov, Grigory V.
    Via, Laura E.
    Van der Walt, Martie
    Tupasi, Thelma
    Smith, Sarah E.
    Odendaal, Ronel
    Leimane, Vaira
    Kvasnovsky, Charlotte
    Kuznetsova, Tatiana
    Kurbatova, Ekaterina
    Kummik, Tiina
    Kuksa, Liga
    Kliiman, Kai
    Kiryanova, Elena V.
    Kim, HeeJin
    Kim, Chang-ki
    Kazennyy, Boris Y.
    Jou, Ruwen
    Huang, Wei-Lun
    Ershova, Julia
    Erokhin, Vladislav V.
    Diem, Lois
    Contreras, Carmen
    Cho, Sang Nae
    Chernousova, Larisa N.
    Chen, Michael P.
    Campos Caoili, Janice
    Bayona, Jaime
    Akksilp, Somsak
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 59 (08) : 1049 - 1063
  • [6] Organzation W.H, 2020, Roadmap to Implement the Tuberculosis Action Plan for the WHO European Region 2016-2020: Towards Ending Tuberculosis and Multidrugresistant Tuberculosis
  • [7] Sharma A, 2017, LANCET INFECT DIS
  • [8] Stop TB Partnership, GLOB DRUG RES TB IN
  • [9] WHO, 2016, TREAT GUID DRUG RES
  • [10] World Health Organization, 2017, TUB SURV MON EUR 201
1